Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medicenna Therapeutics Corp (MDNA)

Medicenna Therapeutics Corp (MDNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicenna Therapeutics Corp 200-1920 Yonge Street Toronto A6 M4S 3E2 CAN

www.medicenna.com P: 416-648-5555

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 10,933
Enterprise Value, $K -14,487
Shares Outstanding, K 69,637
Annual Sales, $ 0 K
Annual Net Income, $ -7,600 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,130 K
EBIT, $ -10,400 K
EBITDA, $ -12,300 K
60-Month Beta 1.30
% of Insider Shareholders 33.10%
% of Institutional Shareholders 12.38%
Float, K 46,587
% Float 66.90%
Short Volume Ratio 0.24

Growth:

1-Year Return -78.55%
3-Year Return -96.11%
5-Year Return -81.92%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 30.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 07/28/23
Next Earnings Date 11/03/23
Earnings Per Share ttm -0.14
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 33.33%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MDNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.68%
Return-on-Assets % -35.17%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.49
Book Value/Share 0.32
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar